<DOC>
	<DOCNO>NCT01035567</DOCNO>
	<brief_summary>The purpose study assess safety efficacy hybrid revascularization comparison coronary artery bypass grafting among patient multivessel coronary artery disease .</brief_summary>
	<brief_title>Safety Efficacy Study Hybrid Revascularization Multivessel Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Age 18 Angiographically confirm multivessel CAD involve LAD critical ( &gt; 70 % ) lesion least one ( apart LAD ) major epicardial vessel amenable PCI CABG Indication revascularization base upon symptom angina and/or objective evidence myocardial ischaemia Patient willing comply followup visit Patient sign Informed Consent Severe congestive heart failure ( class III IV accord NYHA , pulmonary edema , cardiogenic shock ) time enrollment Prior surgery open pericardium pleura Prior stroke ( within 6 month ) 6 month substantial neurological defect Prior history significant bleeding ( within previous 6 month ) might expect occur PCI/CABG related anticoagulation One chronic total occlusion major coronary territory Left main stenosis ( least 50 % diameter stenosis ) Acute STelevation MI within 72 hour prior enrollment require revascularization Planned simultaneous surgical procedure unrelated coronary revascularization ( e.g . valve repair/replacement , aneurysmectomy , carotid endarterectomy carotid stenting ) Contraindication either CABG , MIDCAB PCI/DES coexist clinical condition Significant leukopenia , neutropenia , thrombocytopenia , anemia , know bleed diathesis . Intolerance contraindication aspirin clopidogrel ticlopidine Extracardiac illness expect limit survival le 5 year e.g . oxygendependent chronic obstructive pulmonary disease , active hepatitis significant hepatic failure , severe renal disease Suspected pregnancy . A pregnancy test administer prerandomization woman childbearing age Concurrent enrollment another clinical trial Patient inaccessible followup visit require protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Multivessel coronary artery disease</keyword>
	<keyword>Hybrid revascularization</keyword>
	<keyword>Coronary Artery Bypass Grafting</keyword>
	<keyword>Percutaneous Coronary Interventions</keyword>
	<keyword>Drug elute stent</keyword>
</DOC>